TopPodcast.com
Menu
  • Home
  • Top Charts
  • Top Networks
  • Top Apps
  • Top Independents
  • Top Podfluencers
  • Top Picks
    • Top Business Podcasts
    • Top True Crime Podcasts
    • Top Finance Podcasts
    • Top Comedy Podcasts
    • Top Music Podcasts
    • Top Womens Podcasts
    • Top Kids Podcasts
    • Top Sports Podcasts
    • Top News Podcasts
    • Top Tech Podcasts
    • Top Crypto Podcasts
    • Top Entrepreneurial Podcasts
    • Top Fantasy Sports Podcasts
    • Top Political Podcasts
    • Top Science Podcasts
    • Top Self Help Podcasts
    • Top Sports Betting Podcasts
    • Top Stocks Podcasts
  • Podcast News
  • About Us
  • Podcast Advertising
  • Contact
Not in our directory?
Add Show Here
Podcast Equipment
Center

toppodcastlogoOur TOPPODCAST Picks

  • Comedy
  • Crypto
  • Sports
  • News
  • Politics
  • True Crime
  • Business
  • Finance

Follow Us

toppodcastlogoStay Connected

    View Top 200 Chart
    Back to Rankings Page
    Health & Fitness

    On The Pen GLP-1 News

    On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. The podcast is in the top 0.5% of all podcasts globally, and On The Pen is a top Substack best-seller.

    Advertise

    Copyright: © 2025 On The Pen With Dave Knapp

    • Apple Podcasts
    • Google Play
    • Spotify
    Latest Episodes:
    Like Ozempic, But You Only Take It Once! Fractyl Health CEO Dr. Harith Rajagopalan Nov 29, 2024
    Show notes

    Send a text

    CEO and Co-Founder of Fractyl Health ($GUTS) Dr. Harith Rajagopalan joins On The Pen to discuss their #Revita and #Rejuva programs for type 2 diabetes and obestity
    https://www.fractyl.com/

    Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!

    🤝 Visit Our Sponsors!
    OTPLinks.com

    Decoding GLP-1 Book
    Decoding GLP-1: A Guide for Friends and Family of Those On The Pen
    Buy Here: https://amzn.to/3Dc66d4
    MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
    Venmo: OnThePen
    Ca$h App: ManOnMounjaro
    BECOME A MEMBER:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
    👉 My Amazon Affiliate Store:
    https://www.amazon.com/shop/manonthemounjaroonthepen
    WATCH MORE!
    📺 We're Live M/W/F at 11 central: onthepen.tv


    📲 Contact Me: dave@onthepen.com
    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.

    Retatrutide Cagrisema & Obesity Medicine Future With Dr. Michael Albert Nov 28, 2024
    Show notes

    Send a text

    Dr Michael Albert and Dave Knapp discuss the current events in GLP-1 medications as well as the horizon of future anti obesity medicine.

    Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!

    🤝 Visit Our Sponsors!
    OTPLinks.com

    Decoding GLP-1 Book
    Decoding GLP-1: A Guide for Friends and Family of Those On The Pen
    Buy Here: https://amzn.to/3Dc66d4
    MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
    Venmo: OnThePen
    Ca$h App: ManOnMounjaro
    BECOME A MEMBER:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
    👉 My Amazon Affiliate Store:
    https://www.amazon.com/shop/manonthemounjaroonthepen
    WATCH MORE!
    📺 We're Live M/W/F at 11 central: onthepen.tv


    📲 Contact Me: dave@onthepen.com
    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.

    Medicare to Cover Zepbound and Wegovy? Nov 26, 2024
    Show notes

    Send a text

    https://www.onthepen.com/post/medicare-medicaide-to-cover-zepbound-here-s-why-it-s-not-as-simple-as-it-sounds

    Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!

    🤝 Visit Our Sponsors!
    OTPLinks.com

    Decoding GLP-1 Book
    Decoding GLP-1: A Guide for Friends and Family of Those On The Pen
    Buy Here: https://amzn.to/3Dc66d4
    MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
    Venmo: OnThePen
    Ca$h App: ManOnMounjaro
    BECOME A MEMBER:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
    👉 My Amazon Affiliate Store:
    https://www.amazon.com/shop/manonthemounjaroonthepen
    WATCH MORE!
    📺 We're Live M/W/F at 11 central: onthepen.tv


    📲 Contact Me: dave@onthepen.com
    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.

    Compound Tirzepatide Future + @FitFlavorFun : OTP EPS 91 Nov 23, 2024
    Show notes

    Send a text

    Ali G. from @FitFlavorFun joins Dave to talk all things GLP-1!

    Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!

    🤝 Visit Our Sponsors!
    OTPLinks.com

    Decoding GLP-1 Book
    Decoding GLP-1: A Guide for Friends and Family of Those On The Pen
    Buy Here: https://amzn.to/3Dc66d4
    MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
    Venmo: OnThePen
    Ca$h App: ManOnMounjaro
    BECOME A MEMBER:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
    👉 My Amazon Affiliate Store:
    https://www.amazon.com/shop/manonthemounjaroonthepen
    WATCH MORE!
    📺 We're Live M/W/F at 11 central: onthepen.tv


    📲 Contact Me: dave@onthepen.com
    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.

    On The Pen: The Weekly Dose 11.19.24 Nov 19, 2024
    Show notes

    Send a text

    https://www.nature.com/articles/d41586-024-03614-9

    https://www.wsj.com/health/pharma/weight-loss-drugs-employer-healthcare-coverage-12817e4f

    https://www.reuters.com/business/healthcare-pharmaceuticals/medicaid-fuels-us-coverage-novo-lilly-weight-loss-drugs-2024-11-18/

    https://www.biospace.com/drug-delivery/novos-wegovy-launched-in-china-at-a-fraction-of-us-price
    https://www.wsj.com/health/pharma/eli-illy-novo-ozempic-zepbound-copycats-e6171fdd

    Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!

    🤝 Visit Our Sponsors!
    OTPLinks.com

    Decoding GLP-1 Book
    Decoding GLP-1: A Guide for Friends and Family of Those On The Pen
    Buy Here: https://amzn.to/3Dc66d4
    MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
    Venmo: OnThePen
    Ca$h App: ManOnMounjaro
    BECOME A MEMBER:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
    👉 My Amazon Affiliate Store:
    https://www.amazon.com/shop/manonthemounjaroonthepen
    WATCH MORE!
    📺 We're Live M/W/F at 11 central: onthepen.tv


    📲 Contact Me: dave@onthepen.com
    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.

    CNN Special: Is Ozempic For You? With Dr. Gupta OTP REVIEW Nov 18, 2024
    Show notes

    Send a text

    Dave reviews the CNN special with Dr Sanjay Gupta on GLP-1 medications.

    Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!

    🤝 Visit Our Sponsors!
    OTPLinks.com

    Decoding GLP-1 Book
    Decoding GLP-1: A Guide for Friends and Family of Those On The Pen
    Buy Here: https://amzn.to/3Dc66d4
    MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
    Venmo: OnThePen
    Ca$h App: ManOnMounjaro
    BECOME A MEMBER:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
    👉 My Amazon Affiliate Store:
    https://www.amazon.com/shop/manonthemounjaroonthepen
    WATCH MORE!
    📺 We're Live M/W/F at 11 central: onthepen.tv


    📲 Contact Me: dave@onthepen.com
    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.

    Dr Spencer Nadolsky: Docs Who Lift Pod | OTP Eps 90 Nov 15, 2024
    Show notes

    Send a text

    Dr Spencer Nadolski of the “Docs Who Life” podcast joins Dave to recap obesity week, and to deep dive into Dave’s ongoing struggle with obesity and type 2 diabetes.

    Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!

    🤝 Visit Our Sponsors!
    OTPLinks.com

    Decoding GLP-1 Book
    Decoding GLP-1: A Guide for Friends and Family of Those On The Pen
    Buy Here: https://amzn.to/3Dc66d4
    MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
    Venmo: OnThePen
    Ca$h App: ManOnMounjaro
    BECOME A MEMBER:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
    👉 My Amazon Affiliate Store:
    https://www.amazon.com/shop/manonthemounjaroonthepen
    WATCH MORE!
    📺 We're Live M/W/F at 11 central: onthepen.tv


    📲 Contact Me: dave@onthepen.com
    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.

    Novo Nordisk's War on Compound Semaglutide, Maritide Has Some Negative News Nov 12, 2024
    Show notes

    Send a text

    In this episode of On The Pen: The Weekly Dose, host Dave Knapp dives into the latest updates in obesity medicine, with insightful takes on current treatment breakthroughs, new medication approvals, and tips on navigating healthcare options. This week’s deep dive also touches on emerging trends in GLP-1 therapy and how recent shifts may impact accessibility for patients. Whether you’re just starting your journey or a long-time follower of GLP-1 news, this episode brings you the essentials. ​
    Maritide Bone Density Loss:
    https://www.statnews.com/2024/11/12/amgen-maritide-obesity-drug-candidate-data/
    Catalent Novo Merger:
    https://www.biospace.com/deals/lilly-vs-novo-the-he-said-she-said-row-about-catalents-glp-1-work
    Novo War On Compounds:
    https://www.onthepen.com/post/shocking-truth-about-semaglutide-what-novo-nordisk-doesn-t-want-you-to-know
    Drug Shortage Policy Reform Request (VOTE!):
    https://forum.policiesforpeople.com/t/compound-tirzepatide-and-semaglutide-transparency-in-fda-drug-shortage-process-503b-protection/7821

    Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!

    🤝 Visit Our Sponsors!
    OTPLinks.com

    Decoding GLP-1 Book
    Decoding GLP-1: A Guide for Friends and Family of Those On The Pen
    Buy Here: https://amzn.to/3Dc66d4
    MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
    Venmo: OnThePen
    Ca$h App: ManOnMounjaro
    BECOME A MEMBER:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
    👉 My Amazon Affiliate Store:
    https://www.amazon.com/shop/manonthemounjaroonthepen
    WATCH MORE!
    📺 We're Live M/W/F at 11 central: onthepen.tv


    📲 Contact Me: dave@onthepen.com
    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.

    Viking Therapeutics and AstraZeneca Steal The Show at Obesity Week! Nov 05, 2024
    Show notes

    Send a text

    Semaglutide News: https://www.onthepen.com/post/select-trial-update-semaglutide-s-cardiovascular-benefits-and-psychiatric-safety-profile-highlighte
    Viking Therapeutics News:
    https://www.onthepen.com/post/vk2735-vikingtide
    AstraZeneca News:
    https://www.onthepen.com/post/astrazeneca-s-azd5004-a-power-move-in-obesity-medicine

    Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!

    🤝 Visit Our Sponsors!
    OTPLinks.com

    Decoding GLP-1 Book
    Decoding GLP-1: A Guide for Friends and Family of Those On The Pen
    Buy Here: https://amzn.to/3Dc66d4
    MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
    Venmo: OnThePen
    Ca$h App: ManOnMounjaro
    BECOME A MEMBER:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
    👉 My Amazon Affiliate Store:
    https://www.amazon.com/shop/manonthemounjaroonthepen
    WATCH MORE!
    📺 We're Live M/W/F at 11 central: onthepen.tv


    📲 Contact Me: dave@onthepen.com
    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.

    Lilly Earnings Call Analysis: Why Zepbound Missed Earnings Oct 31, 2024
    Show notes

    Send a text

    Dave brings his analysis of the Q3 Eli Lilly earnings call, and how it relates to the future of access to obesity medicine. Also there is an important clarification on the Zepbound savings card that you should not miss.
    #Zepbound #Mounjaro #Tirzepatide

    Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!

    🤝 Visit Our Sponsors!
    OTPLinks.com

    Decoding GLP-1 Book
    Decoding GLP-1: A Guide for Friends and Family of Those On The Pen
    Buy Here: https://amzn.to/3Dc66d4
    MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
    Venmo: OnThePen
    Ca$h App: ManOnMounjaro
    BECOME A MEMBER:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
    👉 My Amazon Affiliate Store:
    https://www.amazon.com/shop/manonthemounjaroonthepen
    WATCH MORE!
    📺 We're Live M/W/F at 11 central: onthepen.tv


    📲 Contact Me: dave@onthepen.com
    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.

    Previous 1 13 14 15 16 17 22 Next

    Related Podcasts

    Fresh Air

    1

    Fresh Air Arts
    Twenty Thousand Hertz

    2

    Twenty Thousand Hertz Arts
    The Black Tapes

    3

    The Black Tapes Arts
    Snap Judgment

    4

    Snap Judgment Arts
    Here’s The Thing with Alec Baldwin

    5

    Here’s The Thing with Alec Baldwin Arts
    The NoSleep Podcast – Creative Reason Media Inc.

    6

    The NoSleep Podcast – Creative Reason Media Inc. Arts
    footer-logo

    Contact Us

    Toll Free: 844-670-7747

    Links

    • Home
    • Top Charts
    • Networks
    • Apps
    • Independents Podcasts
    • Podcast Advertising
    • Podcast News
    • Contact Us
    • About Us
    • Analytics & Insights

    Stay Connected

      Privacy, Terms of Use & Our Code of Ethics Protecting Content Creators Copyrights